Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Retrospect Reviews of PNH Tests with Long-Term Follow-up in a Single Institution

Weiwei Wang, PhD, Gabrielle Meyers, MD, Haibo Li, Ying Wang, Lisong Shen, MD PhD, Guang Fan, MD PhD

Blood (2019) 134 (Supplement_1): 948.

https://doi.org/10.1182/blood-2019-124896

Published: 2019

Journal Articles

Equate, a Phase 1b/2 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of a Novel Targeted Anti-CD6 Therapy, Itolizumab, in Subjects with Newly Diagnosed Acute Graft Versus Host Disease

Blood (2019) 134 (Supplement_1): 4516.

https://doi.org/10.1182/blood-2019-127325

Published: 2019

Journal Articles

Feasibility and Cost Analysis of Day 4 Granulocyte Colony-Stimulating Factor Mobilized Peripheral Blood Progenitor Cell Collection from HLA-Matched Sibling Donors

Laura F. Newell, MD, Rebekah Knight, Kelsea Shoop, Sara Murray, Rogelyn Kwock, NP, Carol Jacoby, NP, Susan Slater, NP, Bryon Allen, NP, Brad Cota, MBA, Peggy Appel, Rachel J. Cook, MD, Richard T. Maziarz, MD, Gabrielle Meyers, MD

Blood (2018) 132 (Supplement 1): 4558.

https://doi.org/10.1182/blood-2018-99-120342

Published: 2018

Journal Articles

Healthcare Consumption Amongst Older Patients with High Risk AML Treated with Hypomethylating Agents Is Similar to That of Patients Receiving Induction Chemotherapy

Curtis A Lachowiez, MD, Matthew Kearney, MD, Gabrielle Meyers, MD, Rachel J. Cook, MD

Blood (2017) 130 (Supplement 1): 2155.

https://doi.org/10.1182/blood.V130.Suppl_1.2155.2155

Published: 2017

Journal Articles

Identifying Unexpected Inherited Marrow Failure Syndromes in Adults Presenting with Aplastic Anemia, MDS or Solid Tumors

Curtis Lachowiez, MD, Gabrielle Meyers, MD

Blood (2016) 128 (22): 5071.

https://doi.org/10.1182/blood.V128.22.5071.5071

Published: 2016

Journal Articles

Elevated Placental Growth Factor Levels after Allogeneic Hematopoietic Cell Transplantation: Clinical and Peripheral Blood Mononuclear Cell Receptor Expression Correlates

Laura Newell, MD, Gabrielle Meyers, MD, Shernan G. Holtan, MD

Blood (2014) 124 (21): 5870.

https://doi.org/10.1182/blood.V124.21.5870.5870

Published: 2014

Journal Articles

The Contribution of Toll-like Receptor (TLR) Pathway Hyper-Reactivity to Clonal Selection in Secondary MDS and AML

Laura F. Newell, MD, R. K. Rathbun, Michael R Garbati, PhD, Kim-Hien T. Dao, DO,PhD, Shernan G. Holtan, MD, Rachel J Cook, MD MS, Gabrielle Meyers, MD, Grover C. Bagby, MD MACP

Blood (2014) 124 (21): 4621.

https://doi.org/10.1182/blood.V124.21.4621.4621

Published: 2014

Journal Articles

Circulating Angiogenic Factors As Biomarkers of Acute Gvhd Onset and Response to Therapy: Repair and Regeneration Versus Endothelial Damage and Inflammation

Shernan G. Holtan, MD, Michael R. Verneris, MD, Kirk R. Schultz, MD, Laura Newell, MD, Gabrielle Meyers, MD, Fiona C. He, MD, Todd E. DeFor, MS, Margaret L. MacMillan, MD, Sarah A. Cooley, MD MS, Angela Panoskaltsis-Mortari, PhD, Daniel J. Weisdorf, MD

Blood (2014) 124 (21): 2489.

https://doi.org/10.1182/blood.V124.21.2489.2489

Published: 2014

Journal Articles

Disease-Related Symptoms Reported across a Broad Population of Patients with Paroxysmal Nocturnal Hemoglobinuria.

Gabrielle Meyers, MD, Ilene Weitz, MD, Thierry Lamy, MD, Jean-Yves Cahn, MD, Henk-André Kroon, MD, Beth Severino, BS, Maria Teresa Uranga, MD, Miguel Sanz Alonso, MD, José Antonio García Vela, MD, Anita Hill, MB, ChB

Blood (2007) 110 (11): 3683.

https://doi.org/10.1182/blood.V110.11.3683.3683

Published: 2007

Journal Articles

Clonal Expansion in Paroxysmal Nocturnal Hemoglobinuria (PNH): Expression of Mutant HMGA2 Suggests That PNH Is a Benign Tumor of the Bone Marrow.

Norimitsu Inoue, MD, PhD, Tomohisa Izui, MD, Yoshiko Murakmai, MD, PhD, Yuichi Endo, PhD, Jun-ichi Nishimura, MD, PhD, Yuzuru Kanakura, MD, PhD, Gabrielle Meyers, MD, Carl Wittwer, MD, PhD, Zhong Chen, MD, William Babcock, MD, Debra Frei-Lahr, MD, Charles Parker, MD, Taroh Kinoshita, PhD

Blood (2005) 106 (11): 3533.

https://doi.org/10.1182/blood.V106.11.3533.3533

Published: 2005

Journal Articles

Comparison of Gene Expression in Dominant and Non-Dominant PIG-A Mutant Clones in Paroxysmal Nocturnal Hemoglobinuria (PNH).

Gabrielle Meyers, MD, Charles J. Parker, MD

Blood (2004) 104 (11): 2830.

https://doi.org/10.1182/blood.V104.11.2830.2830

Published: 2004

Journal Articles

Identification of a Novel Hematopoietic Cell Translocation in a Patient with Paroxysmal Nocturnal Hemoglobinuria (PNH).

Gabrielle Meyers, MD, William H. Babcock, MD, Robert G. Best, PhD, Charles J. Parker, MD

Blood (2004) 104 (11): 3717.

https://doi.org/10.1182/blood.V104.11.3717.3717

Published: 2004

NARROW

Retrospect Reviews of PNH Tests with Long-Term Follow-up in a Single Institution

Equate, a Phase 1b/2 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of a Novel Targeted Anti-CD6 Therapy, Itolizumab, in Subjects with Newly Diagnosed Acute Graft Versus Host Disease

Feasibility and Cost Analysis of Day 4 Granulocyte Colony-Stimulating Factor Mobilized Peripheral Blood Progenitor Cell Collection from HLA-Matched Sibling Donors

Healthcare Consumption Amongst Older Patients with High Risk AML Treated with Hypomethylating Agents Is Similar to That of Patients Receiving Induction Chemotherapy

Identifying Unexpected Inherited Marrow Failure Syndromes in Adults Presenting with Aplastic Anemia, MDS or Solid Tumors

Elevated Placental Growth Factor Levels after Allogeneic Hematopoietic Cell Transplantation: Clinical and Peripheral Blood Mononuclear Cell Receptor Expression Correlates

The Contribution of Toll-like Receptor (TLR) Pathway Hyper-Reactivity to Clonal Selection in Secondary MDS and AML

Circulating Angiogenic Factors As Biomarkers of Acute Gvhd Onset and Response to Therapy: Repair and Regeneration Versus Endothelial Damage and Inflammation

Disease-Related Symptoms Reported across a Broad Population of Patients with Paroxysmal Nocturnal Hemoglobinuria.

Clonal Expansion in Paroxysmal Nocturnal Hemoglobinuria (PNH): Expression of Mutant HMGA2 Suggests That PNH Is a Benign Tumor of the Bone Marrow.

Comparison of Gene Expression in Dominant and Non-Dominant PIG-A Mutant Clones in Paroxysmal Nocturnal Hemoglobinuria (PNH).

Identification of a Novel Hematopoietic Cell Translocation in a Patient with Paroxysmal Nocturnal Hemoglobinuria (PNH).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only